N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine
C23H27FN4 — CID 153383588
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine
N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine (PubChem CID 153383588) has the molecular formula C23H27FN4 and a molecular weight of 378.50 g/mol. Its IUPAC name is N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine.
Molecular Properties
| Compound Name | N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine |
|---|---|
| PubChem CID | 153383588 |
| Molecular Formula | C23H27FN4 |
| Molecular Weight | 378.50 g/mol |
| Exact Mass | 378.22 |
| IUPAC Name | N-[4-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2,6-dimethylphenyl]-1-piperidin-4-ylethanimine |
| SMILES | C/C(=N\c1c(C)cc(-c2cc(F)c3nc(C)cn3c2)cc1C)C1CCNCC1 |
| InChI | InChI=1S/C23H27FN4/c1-14-9-19(20-11-21(24)23-26-16(3)12-28(23)13-20)10-15(2)22(14)27-17(4)18-5-7-25-8-6-18/h9-13,18,25H,5-8H2,1-4H3/b27-17+ |
| InChIKey | YEZRCPOCSMBXPG-WPWMEQJKSA-N |
| XLogP | 5.16 |
| TPSA | 41.69 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 378.50 |
| LogP ≤ 5 | 5.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153383588 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.